Literature DB >> 16005524

PSGL-1 is not required for development of experimental autoimmune encephalomyelitis.

Inga Osmers1, Daniel C Bullard, Scott R Barnum.   

Abstract

Adhesion molecules are essential mediators for lymphocyte trafficking through the blood-brain barrier into the CNS in multiple sclerosis and its animal model experimental autoimmune encephalomyelitis (EAE). However, the role of the selectin molecules and their ligand, P-selectin glycoprotein-1 (PSGL-1) which mediates tethering and rolling of the leukocytes in demyelinating disease remains controversial. This study demonstrates that mice deficient in PSGL-1 are not significantly different in the development and progression of EAE compared to wild type controls. Our observations suggest that PSGL-1-selectin interactions are redundant and not required for the development of EAE. Our data also indicate that other adhesion molecules are necessary for the initial rolling events leading to leukocyte infiltration into the CNS during EAE.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16005524     DOI: 10.1016/j.jneuroim.2005.06.001

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  8 in total

1.  Disruption of the beta2-integrin CD11d (alphaDbeta2) gene fails to protect against experimental autoimmune encephalomyelitis.

Authors:  Jillian E Adams; Matthew S Webb; Xianchen Hu; Don Staunton; Scott R Barnum
Journal:  J Neuroimmunol       Date:  2007-01-23       Impact factor: 3.478

Review 2.  The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction.

Authors:  Britta Engelhardt; Lydia Sorokin
Journal:  Semin Immunopathol       Date:  2009-09-25       Impact factor: 9.623

Review 3.  Adhesion molecules in CNS disorders: biomarker and therapeutic targets.

Authors:  Qingyi Ma; Sheng Chen; Damon Klebe; John H Zhang; Jiping Tang
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-05-01       Impact factor: 4.388

4.  CD43 Functions as an E-Selectin Ligand for Th17 Cells In Vitro and Is Required for Rolling on the Vascular Endothelium and Th17 Cell Recruitment during Inflammation In Vivo.

Authors:  Francisco Velázquez; Anna Grodecki-Pena; Andrew Knapp; Ane M Salvador; Tania Nevers; Kevin Croce; Pilar Alcaide
Journal:  J Immunol       Date:  2015-12-23       Impact factor: 5.422

5.  Regulatory T cells suppress the late phase of the immune response in lymph nodes through P-selectin glycoprotein ligand-1.

Authors:  Stefano Angiari; Barbara Rossi; Laura Piccio; Bernd H Zinselmeyer; Simona Budui; Elena Zenaro; Vittorina Della Bianca; Simone D Bach; Elio Scarpini; Matteo Bolomini-Vittori; Gennj Piacentino; Silvia Dusi; Carlo Laudanna; Anne H Cross; Mark J Miller; Gabriela Constantin
Journal:  J Immunol       Date:  2013-10-30       Impact factor: 5.422

6.  Fluids and barriers of the CNS establish immune privilege by confining immune surveillance to a two-walled castle moat surrounding the CNS castle.

Authors:  Britta Engelhardt; Caroline Coisne
Journal:  Fluids Barriers CNS       Date:  2011-01-18

7.  Multiple sclerosis and the blood-central nervous system barrier.

Authors:  Alan M Palmer
Journal:  Cardiovasc Psychiatry Neurol       Date:  2013-01-15

8.  Genetic mouse models to study blood-brain barrier development and function.

Authors:  Fabien Sohet; Richard Daneman
Journal:  Fluids Barriers CNS       Date:  2013-01-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.